Back to blog
gdp guidelinesgdp certificationgood distribution practice pharma

GDP Guidelines Explained — What Pharma Shippers Need to Know in 2026

Good Distribution Practice 2026 without the marketing fluff. Obligations, certification, cost and the 3 most frequent audit findings — concise for procurement and QA.

May 29, 2026·7 min. read·TempSecure Redaktion
GDP-certified pharma warehouse with temperature-controlled boxes

Anyone shipping medicinal products will inevitably run into one acronym: GDP. The Good Distribution Practice guidelines have been EU-mandatory for years — and 2026 brings sharper enforcement. Here are the answers to the most common questions from procurement, quality and dispatch.

What exactly is GDP?

GDP stands for Good Distribution Practice — the EU framework for the distribution of medicinal products for human use. The legal basis is European Commission guideline 2013/C 343/01; in Germany it is additionally anchored in section 52a of the Medicines Act (AMG). It sets out in binding terms how medicinal products must be stored, transported and handed over so that the active ingredient and efficacy remain intact all the way to the patient.

Unlike GMP (for manufacturing), GDP covers the entire distribution path: from leaving production through wholesale, freight forwarder and intermediate storage to the pharmacy or clinic. Anyone in this chain — even for a single leg — is obliged to operate to GDP standards.

Practical tip

GDP is not a marketing label. It is EU law. Transporting human medicinal products without a valid GDP authorisation in Germany risks fines of up to 25,000 EUR per breach plus withdrawal of the wholesale licence under section 52a AMG.

The 5 core obligations of the GDP guidelines

The 2013/C 343/01 guideline runs to 30 pages. For day-to-day distribution, the requirements boil down to five core obligations:

Quality management system (QMS)
Documented SOPs for every process step — from receipt through handover to traceability. At minimum an annual management review.
Qualified personnel
All staff in contact with medicinal products require documented GDP training plus an annual refresher. During inspections, authorities sample training records per employee.
Suitable premises and equipment
Warehouses and transport assets must be qualified (mapping) and calibrated. Temperature loggers per shipment are mandatory, not a nice-to-have.
End-to-end documentation
Every operation must remain auditable for at least 5 years. In the event of an incident, the chain of custody must be demonstrable within 24 hours.
Risk and deviation management
Temperature excursions, breakages and delays are captured, assessed and worked through using CAPA (corrective and preventive actions) — not merely filed away.

Who needs a GDP authorisation?

An own GDP authorisation is required by anyone who owns, stores or distributes human medicinal products — even if only for a short time. In practice there are three clear profiles:

Manufacturer
Pharma producers and contract manufacturers

Already covered by their GMP authorisation — but as soon as own distribution is operated (e.g. direct shipment to clinics), GDP applies on top.

Wholesale
Pharma wholesalers and distributors

Full GDP obligation, no exceptions. The wholesale authorisation under section 52a AMG requires a valid GDP inspection by the state authority.

Logistics
Freight forwarders and couriers

Acting on behalf of others in Germany does not require an own section 52a licence, but operations MUST be GDP-compliant — accountability stays with the contracting party, the entire chain gets audited.

The certification process step by step

Anyone introducing GDP for the first time should realistically plan 6 to 12 months of lead time. The process runs through five stages — each with its own pitfalls:

1
Gap analysis
An external auditor compares the as-is state with the 30 pages of the GDP guideline. Output: a findings list classified Major/Minor.
2
Build SOPs
Per findings block an SOP is drafted, released by the QM officer and trained out to the team. Rule of thumb: 25 to 40 SOPs for a mid-sized forwarder.
3
Audit preparation
Mock audit by an external consultant. This is where 80 % of the remaining gaps surface — document chaos, missing training records, uncalibrated loggers.
4
Authority inspection
Responsibility lies with the state authority (in Hesse, for instance, the Darmstadt Regional Council). The inspection takes 1 to 3 days; findings are documented in writing.
5
CAPA and re-inspection
Major findings must be answered with an action plan within 30 days. A re-inspection follows where required — then the wholesale authorisation is granted.

2026: where pharma shippers most often fail

Each year we see hundreds of audit reports — our own and those of contracting parties. The patterns are remarkably consistent: it is not the exotic edge cases but the same three problem areas that produce most findings in 2026.

Watch out

The 2026 trend: authorities are stepping up scrutiny of the last mile. Couriers and clinic delivery services that previously flew under the radar are now in focus. This applies particularly to dry-ice shipments and direct delivery to hospitals.

Audits with major findings
62 %
Industry average 2025 (EMA Inspections Report)
Ø time to re-certification
8 mo.
after a withdrawn authorisation
Ø cost of first GDP certification
45–80 k EUR
mid-sized forwarder, incl. consulting + audit

Common myths — and what is actually true

In B2B pharma logistics sales we keep meeting the same half-truths. Three of them are particularly hard to kill:

Myth 1: "ISO 9001 is enough." — Not true. ISO 9001 is sector-neutral quality management and says nothing about temperature, medicinal products or active ingredients. Anyone who wants the detailed difference can read our in-depth comparison in GDP vs ISO 9001 for pharma transport.

Myth 2: "My wholesaler is GDP-certified, so I am too." — Wrong. GDP accountability travels with the goods. As soon as a forwarder or courier takes over the shipment, they carry full shared responsibility — and must in turn operate to GDP standards.

Myth 3: "With a data logger everything is covered." — A logger without a calibrated state, without packaging mapping and without a documented escalation on deviation is worthless in an audit. The authority does not ask for the dataset, it asks for the process behind it.

When does GDP pay off for my shipping operation?

GDP certification is not a gut decision — it is mandatory the moment human medicinal products are in play. The more frequently asked question is therefore: is it worth using a GDP-certified specialist forwarder rather than certifying in-house?

Rule of thumb

Below 200 pharma shipments per year, a certified specialist forwarder almost always pays off more than your own GDP certification.

Certification and maintenance costs only amortise from a regular shipment volume upwards. Below that, external providers with established GDP infrastructure are cheaper and more audit-proof.

FAQ — the 5 most common questions

How long does GDP certification take?

First-time certification: 6 to 12 months from project start. From the application to the state authority to the inspection typically takes 4 to 8 months — the rest goes into internal preparation, SOP build-out and mock audit.

How often does re-certification happen?

The GDP authorisation under section 52a AMG is open-ended, but the state authority typically inspects every 2 to 5 years. Triggered inspections (e.g. following complaints, customer audits or a change of responsible person) can come at any time on top.

What does GDP certification cost?

For a mid-sized pharma forwarder in Germany: 45,000 to 80,000 EUR initial investment (consulting, SOP build-out, mock audit, authority fees, possible equipment upgrades). Running costs: 15,000 to 30,000 EUR per year for QMS upkeep, training, re-audits and calibrations.

Do I also need GDP for veterinary medicinal products?

The EU guideline 2013/C 343/01 covers human medicinal products only. Veterinary medicines fall under a separate regulation (EU regulation 2019/6) which sets similar but not identical requirements. Anyone transporting both needs both certifications.

Who is liable when the cold chain breaks?

Primary liability sits with the holder of the wholesale authorisation (usually the manufacturer or distributor). The forwarder is liable internally under freight-forwarder liability (German Commercial Code) plus contractually agreed joint liability. In practice: anyone who runs and documents to GDP standards can effectively exclude joint liability — anyone who does not, carries the full commercial risk.

Looking for a GDP-certified pharma shipper?

TempSecure is GDP- and ISO 9001-certified and moves pharma shipments with calibrated loggers, 24/7 dispatch and live tracking. Quote within the hour.

GDP & ISO 9001 zertifiziertTive Live-Tracking24/7-DispositionAntwort in unter 1 h

Topics

gdp guidelinesgdp certificationgood distribution practice pharmapharma shipperwholesale authorisationgdp audit findings
GDP Guidelines Explained 2026 | TempSecure